4//SEC Filing
Antibody Investments LLC 4
Accession 0001123292-18-000927
CIK 0001205922other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:49 PM ET
Size
12.4 KB
Accession
0001123292-18-000927
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Antibody Investments LLC
10% Owner
Transactions
- Conversion
Common Stock
2018-08-13+1,346,139→ 1,346,139 total - Conversion
Common Stock
2018-08-13+549,444→ 1,895,583 total - Conversion
Series C Convertible Preferred Stock
2018-08-13−7,205,882→ 0 total→ Common Stock (1,346,139 underlying) - Conversion
Series D Convertible Preferred Stock
2018-08-13−5,494,505→ 0 total→ Common Stock (549,444 underlying)
Footnotes (2)
- [F1]The reported securities converted into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering.
- [F2]The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001749340
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:49 PM ET
- Size
- 12.4 KB